Oscar Health, Inc. (OSCR)
NYSE: OSCR · Real-Time Price · USD
18.16
+1.43 (8.55%)
Nov 26, 2025, 4:00 PM EST - Market closed
Oscar Health Revenue
Oscar Health had revenue of $2.99B in the quarter ending September 30, 2025, with 23.21% growth. This brings the company's revenue in the last twelve months to $11.29B, up 37.38% year-over-year. In the year 2024, Oscar Health had annual revenue of $9.18B with 56.54% growth.
Revenue (ttm)
$11.29B
Revenue Growth
+37.38%
P/S Ratio
0.41
Revenue / Employee
$4,703,595
Employees
2,400
Market Cap
4.80B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 9.18B | 3.31B | 56.54% |
| Dec 31, 2023 | 5.86B | 1.90B | 47.92% |
| Dec 31, 2022 | 3.96B | 2.07B | 109.27% |
| Dec 31, 2021 | 1.89B | 1.50B | 384.43% |
| Dec 31, 2020 | 390.99M | -84.59M | -17.79% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
OSCR News
- 23 hours ago - Health Insurers Stocks Reflect Obamacare Subsidy Deal Can Be Reached - Forbes
- 1 day ago - Why This Health Care Stock Has Gained 35% This Week - Investopedia
- 2 days ago - OSCR Stock Review: Strong Growth Meets Attractive Valuation - Forbes
- 2 days ago - Biggest Stock Movers Today, Nov. 24: AVGO, NVO, & More - The Motley Fool
- 3 days ago - Prediction: 2 Stocks That Will Be Worth More Than SoundHound AI 5 Years From Now - The Motley Fool
- 3 days ago - Anticipation of This Trump Proposal Is Sending Health Insurance Stocks Higher Monday - Investopedia
- 3 days ago - Oscar Health's Transition Continues Following a Stake Reduction by Glynn Capital - The Motley Fool
- 3 days ago - Oscar Health stock: why Obamacare extension isn't a strong enough reason to own it - Invezz